Bio-Rad loans €400M to Sartorius-Herbst at 1.5% plus appreciation rights

BIO-RAD LABORATORIES, INC.

Loan of €400 million to Sartorius-Herbst Beteiligungen II GmbH at 1.5% per annum plus value appreciation rights.
Maturity on January 31, 2029, subject to early termination provisions.
Proceeds used to partially finance acquisition of interests under the Sartorius Trust from another beneficiary.
Loan collateralized by pledge of trust interests under the Sartorius Trust.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.